Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hideki Fujii

Showing results (501-510 of 556) with videos related to

Pageof 56
Sort By:
Hepatology Communications|September 24, 2021
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLDHirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka, et al.
Investigational New Drugs|August 30, 2024
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinomaNami Mori, Nobuharu Tamaki, Shintaro Takaki, et al.
Anticancer Research|August 28, 2024
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular CarcinomaNobuharu Tamaki, Nami Mori, Shintaro Takaki, et al.
Journal of Gastroenterology and Hepatology|January 23, 2019
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosisKazuhisa Kodama, Takumi Kawaguchi, Hideyuki Hyogo, et al.
FEBS Open Bio|September 17, 2022
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21Etsushi Kawamura, Tsutomu Matsubara, Atsuko Daikoku, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 20, 2014
Exploring the length of the common channel of pancreaticobiliary maljunction on magnetic resonance cholangiopancreatographyFumihide Itokawa, Terumi Kamisawa, Toshiaki Nakano, et al.
Hepatology Communications|April 16, 2021
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 DiabetesHiroshi Ishiba, Yoshio Sumida, Yuya Seko, et al.
Anticancer Research|September 15, 2019
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular CarcinomaAya Takahashi, Michihisa Moriguchi, Yuya Seko, et al.
Kidney International Reports|May 2, 2022
Detecting <i>MUC1</i> Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney DiseaseEri Okada, Naoya Morisada, Tomoko Horinouchi, et al.
Journal of Gastroenterology|May 27, 2018
Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center studyHiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, et al.
Pageof 56

Showing results (501-510 of 556) with videos related to

Sort By:
Pageof 56
Hepatology Communications|September 24, 2021
Ipragliflozin Improves the Hepatic Outcomes of Patients With Diabetes with NAFLDHirokazu Takahashi, Takaomi Kessoku, Miwa Kawanaka, et al.
Investigational New Drugs|August 30, 2024
Treatment response to durvalumab plus tremelimumab after progression with previous immune checkpoint inhibitor in unresectable hepatocellular carcinomaNami Mori, Nobuharu Tamaki, Shintaro Takaki, et al.
Anticancer Research|August 28, 2024
Change in Liver Function in Durvalumab Plus Tremelimumab Treatment for Unresectable Hepatocellular CarcinomaNobuharu Tamaki, Nami Mori, Shintaro Takaki, et al.
Journal of Gastroenterology and Hepatology|January 23, 2019
Clinical features of hepatocellular carcinoma in nonalcoholic fatty liver disease patients without advanced fibrosisKazuhisa Kodama, Takumi Kawaguchi, Hideyuki Hyogo, et al.
FEBS Open Bio|September 17, 2022
Suppression of intrahepatic cholangiocarcinoma cell growth by SKI via upregulation of the CDK inhibitor p21Etsushi Kawamura, Tsutomu Matsubara, Atsuko Daikoku, et al.
Journal of Hepato-Biliary-Pancreatic Sciences|September 20, 2014
Exploring the length of the common channel of pancreaticobiliary maljunction on magnetic resonance cholangiopancreatographyFumihide Itokawa, Terumi Kamisawa, Toshiaki Nakano, et al.
Hepatology Communications|April 16, 2021
Type IV Collagen 7S Is the Most Accurate Test For Identifying Advanced Fibrosis in NAFLD With Type 2 DiabetesHiroshi Ishiba, Yoshio Sumida, Yuya Seko, et al.
Anticancer Research|September 15, 2019
Impact of Relative Dose Intensity of Early-phase Lenvatinib Treatment on Therapeutic Response in Hepatocellular CarcinomaAya Takahashi, Michihisa Moriguchi, Yuya Seko, et al.
Kidney International Reports|May 2, 2022
Detecting <i>MUC1</i> Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney DiseaseEri Okada, Naoya Morisada, Tomoko Horinouchi, et al.
Journal of Gastroenterology|May 27, 2018
Correction to: The novel cutoff points for the FIB4 index categorized by age increase the diagnostic accuracy in NAFLD: a multi-center studyHiroshi Ishiba, Yoshio Sumida, Saiyu Tanaka, et al.
Pageof 56